Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

Journal: Nature Medicine

Published: 2018-11-26

DOI: 10.1038/s41591-018-0255-8

Affiliations: 7

Authors: 21

Go to article
Institutions FC
University Medical Center Groningen (UMCG), RUG, Netherlands 0.71
Genentech, Inc., United States of America (USA) 0.19
Julius Center for Health Sciences and Primary Care, UU, Netherlands 0.05
F. Hoffmann-La Roche AG, Switzerland 0.05

Return